7-octadecynoic acid
7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.
Cross Reference
There are no associated biomedical information in the current reference collection.
Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.
Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.
Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid
All references with 7-octadecynoic acid
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Sagar DR et al. | Osteoprotegerin reduces the development of pain behaviour and joint pathology in a model of osteoarthritis. | 2014 | Ann. Rheum. Dis. | pmid:23723320 |
| Bjerre M et al. | Osteoprotegerin independently predicts mortality in patients with stable coronary artery disease: the CLARICOR trial. | 2014 | Scand. J. Clin. Lab. Invest. | pmid:25026506 |
| Liu M et al. | Curculigoside improves osteogenesis of human amniotic fluid-derived stem cells. | 2014 | Stem Cells Dev. | pmid:24007307 |
| Zhao H et al. | Long-term resveratrol treatment prevents ovariectomy-induced osteopenia in rats without hyperplastic effects on the uterus. | 2014 | Br. J. Nutr. | pmid:24073920 |
| Ghorbanihaghjo A et al. | Osteoprotegerin and soluble receptor activator of nuclear factor-kappa B ligand in exudative age-related macular degeneration. | 2014 | Acta Med Iran | pmid:24901855 |
| Dzgoeva FU et al. | [Osteoprotegerin and fibroblast growth factor 23 in the development of cardiovascular events in chronic kidney disease]. | 2014 | Ter. Arkh. | pmid:25095658 |
| Honma M et al. | Regulatory mechanisms of RANKL presentation to osteoclast precursors. | 2014 | Curr Osteoporos Rep | pmid:24477414 |
| Lewis JR et al. | Elevated osteoprotegerin predicts declining renal function in elderly women: a 10-year prospective cohort study. | 2014 | Am. J. Nephrol. | pmid:24457210 |
| Cao H et al. | Preoperative serum receptor activator of nuclear factor-κB ligand/osteoprotegerin predict stabilization of spontaneously restored sinus rhythm in persistent atrial fibrillation patients after mitral valve surgery. | 2014 | Cardiology | pmid:24434592 |
| Miller RE et al. | RANKL inhibition blocks osteolytic lesions and reduces skeletal tumor burden in models of non-small-cell lung cancer bone metastases. | 2014 | J Thorac Oncol | pmid:24496001 |
| Wang F et al. | Association analysis between g.18873C>T and g.27522G>A genetic polymorphisms of OPG and bone mineral density in Chinese postmenopausal women. | 2014 | Biomed Res Int | pmid:25580430 |
| Ostrowska Z et al. | Selected adipose tissue hormones, bone metabolism, osteoprotegerin and receptor activator of nuclear factor-kB ligand in postmenopausal obese women. | 2014 | Endokrynol Pol | pmid:25554611 |
| Shen A et al. | Role of osteoprotegerin and its gene polymorphisms in the occurrence of left ventricular hypertrophy in essential hypertensive patients. | 2014 | Medicine (Baltimore) | pmid:25546658 |
| Dessein PH et al. | Independent relationship of osteoprotegerin concentrations with endothelial activation and carotid atherosclerosis in patients with severe rheumatoid arthritis. | 2014 | J. Rheumatol. | pmid:24488413 |
| Irtiuga OB et al. | [Concentration of osteoprotegerin and RANKL in blood serum of patients with aortic stenosis]. | 2014 | Kardiologiia | pmid:25178077 |
| MacMillan AK et al. | Similar healthy osteoclast and osteoblast activity on nanocrystalline hydroxyapatite and nanoparticles of tri-calcium phosphate compared to natural bone. | 2014 | Int J Nanomedicine | pmid:25506216 |
| Tella SH and Gallagher JC | Prevention and treatment of postmenopausal osteoporosis. | 2014 | J. Steroid Biochem. Mol. Biol. | pmid:24176761 |
| Jiang Y et al. | Achyranthes bidentata extract exerts osteoprotective effects on steroid-induced osteonecrosis of the femoral head in rats by regulating RANKL/RANK/OPG signaling. | 2014 | J Transl Med | pmid:25471933 |
| Lenglet S et al. | Statin treatment is associated with reduction in serum levels of receptor activator of NF-κB ligand and neutrophil activation in patients with severe carotid stenosis. | 2014 | Mediators Inflamm. | pmid:24648660 |
| Takeshita S et al. | Age-related marrow adipogenesis is linked to increased expression of RANKL. | 2014 | J. Biol. Chem. | pmid:24753250 |
| Akiyama T et al. | Porphyromonas gingivalis-derived lysine gingipain enhances osteoclast differentiation induced by tumor necrosis factor-α and interleukin-1β but suppresses that by interleukin-17A: importance of proteolytic degradation of osteoprotegerin by lysine gingipain. | 2014 | J. Biol. Chem. | pmid:24755218 |
| Zhang Z et al. | High-dose diosgenin reduces bone loss in ovariectomized rats via attenuation of the RANKL/OPG ratio. | 2014 | Int J Mol Sci | pmid:25257532 |
| Kang JH et al. | Osteoprotegerin expressed by osteoclasts: an autoregulator of osteoclastogenesis. | 2014 | J. Dent. Res. | pmid:25256714 |
| Cao H et al. | Force-induced Adrb2 in periodontal ligament cells promotes tooth movement. | 2014 | J. Dent. Res. | pmid:25252876 |
| Prates TP et al. | NOD2 contributes to Porphyromonas gingivalis-induced bone resorption. | 2014 | J. Dent. Res. | pmid:25239844 |
| Yamamoto N et al. | Regulation by resveratrol of prostaglandin E2-stimulated osteoprotegerin synthesis in osteoblasts. | 2014 | Int. J. Mol. Med. | pmid:25234201 |
| Olivares-Navarrete R et al. | Osteoblast lineage cells can discriminate microscale topographic features on titanium-aluminum-vanadium surfaces. | 2014 | Ann Biomed Eng | pmid:25227453 |
| Giuliani AL et al. | Trophic activity of human P2X7 receptor isoforms A and B in osteosarcoma. | 2014 | PLoS ONE | pmid:25226385 |
| Köttstorfer J et al. | Are OPG and RANKL involved in human fracture healing? | 2014 | J. Orthop. Res. | pmid:25212894 |
| Esteghamati A et al. | Serum osteoprotegerin in relation to metabolic status, severity, and estimated risk of subsequent coronary heart disease. | 2014 | Arch Iran Med | pmid:25204474 |
| Jasiewicz M et al. | Potential pathogenic role of soluble receptor activator of nuclear factor-ĸB ligand and osteoprotegerin in patients with pulmonary arterial hypertension. | 2014 | Pol. Arch. Med. Wewn. | pmid:25188298 |
| Liu YD et al. | Reducing dietary loading decreases mouse temporomandibular joint degradation induced by anterior crossbite prosthesis. | 2014 | Osteoarthr. Cartil. | pmid:24316289 |
| Kuroyanagi G et al. | Resveratrol suppresses prostaglandin F(2α)-induced osteoprotegerin synthesis in osteoblasts: inhibition of the MAP kinase signaling. | 2014 | Arch. Biochem. Biophys. | pmid:24333336 |
| Jung Koo H et al. | Effect of the combinatory mixture of Rubus coreanus Miquel and Astragalus membranaceus Bunge extracts on ovariectomy-induced osteoporosis in mice and anti-RANK signaling effect. | 2014 | J Ethnopharmacol | pmid:24333364 |
| Bosman MC et al. | Decreased affinity of recombinant human tumor necrosis factor-related apoptosis-inducing ligand (rhTRAIL) D269H/E195R to osteoprotegerin (OPG) overcomes TRAIL resistance mediated by the bone microenvironment. | 2014 | J. Biol. Chem. | pmid:24280212 |
| Knevel R et al. | A genetic variant in osteoprotegerin is associated with progression of joint destruction in rheumatoid arthritis. | 2014 | Arthritis Res. Ther. | pmid:24886600 |
| Zinonos I et al. | Pharmacologic inhibition of bone resorption prevents cancer-induced osteolysis but enhances soft tissue metastasis in a mouse model of osteolytic breast cancer. | 2014 | Int. J. Oncol. | pmid:24865346 |
| Klimek E et al. | Differential associations of inflammatory and endothelial biomarkers with disease activity in rheumatoid arthritis of short duration. | 2014 | Mediators Inflamm. | pmid:24864133 |
| Chen H et al. | Runx2 regulates endochondral ossification through control of chondrocyte proliferation and differentiation. | 2014 | J. Bone Miner. Res. | pmid:24862038 |
| Li B et al. | Periodontal ligament stem cells modulate root resorption of human primary teeth via Runx2 regulating RANKL/OPG system. | 2014 | Stem Cells Dev. | pmid:24827498 |
| Lee SI et al. | NOD2 Mediates Odontoblast Differentiation and RANKL Expression. | 2014 | J. Dent. Res. | pmid:24820666 |
| Araújo AA et al. | Azilsartan increases levels of IL-10, down-regulates MMP-2, MMP-9, RANKL/RANK, Cathepsin K and up-regulates OPG in an experimental periodontitis model. | 2014 | PLoS ONE | pmid:24819928 |
| Cianciolo G et al. | Importance of vascular calcification in kidney transplant recipients. | 2014 | Am. J. Nephrol. | pmid:24819032 |
| Sänger N et al. | OPG and PgR show similar cohort specific effects as prognostic factors in ER positive breast cancer. | 2014 | Mol Oncol | pmid:24785095 |
| Hidayat R et al. | Correlation between receptor activator of nuclear factor-κβ ligand (RANKL), and osteoprotegerin (OPG) with cartilage degradation in rheumatoid arthritis patients. | 2014 | Acta Med Indones | pmid:24760805 |
| Jiang XY et al. | TNFRSF11B polymorphisms are associated with metabolic traits in Uyghur and Han ethnic groups. | 2014 | Endocr. Res. | pmid:23772656 |
| Shao X et al. | Metformin rescues the MG63 osteoblasts against the effect of high glucose on proliferation. | 2014 | J Diabetes Res | pmid:24812633 |
| Chauvat A et al. | Clinical validation of IFNγ/IL-10 and IFNγ/IL-2 FluoroSpot assays for the detection of Tr1 T cells and influenza vaccine monitoring in humans. | 2014 | Hum Vaccin Immunother | pmid:24084262 |
| Chaichanasakul T et al. | Diverse osteoclastogenesis of bone marrow from mandible versus long bone. | 2014 | J. Periodontol. | pmid:24003963 |
| Navratilova Z et al. | Osteoprotegerin gene polymorphism is not associated with prosthetic joint infection after total joint arthroplasty in the Czech population. | 2014 | Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub | pmid:22660233 |